Abstract
ObjectiveAnaphylaxis is a severe, potentially fatal allergic reaction best treated with intramuscular epinephrine via epinephrine auto-injectors (AAIs). Our published concerns over laceration injuries to young children associated with AAIs led to this service evaluation of the two administration methods: swing and jab (S&J) and place and press (P&P), to determine potential laceration risk.DesignA trainer EpiPen was used with facepaint placed in the needle indentation which would record the length of movement of the AAI. The two different methods ‘administered’ were alternated. Children were asked to move their leg to simulate a withdrawal reaction. Age, whether they moved, and length of paint mark were recorded.SettingOutpatients waiting area in Noah’s Ark Children’s Hospital, Cardiff.ParticipantsChildren aged 5–11 with no prior knowledge of AAI use.InterventionNo intervention was implemented.Results135 children (mean age 8 years; range 5–11 years) were asked to participate; measurements were taken from 100 children. 50 children moved for one or both methods. For those that moved, S&J mean paint length=8.3 mm (SD 17.4, 95% CI 3.4 to 13.3), P&P mean=3.5 mm (SD 11.0, 95% CI 0.4 to 6.6). Mean difference between methods was 4.8 mm (SD 10.1, 95% CI 1.9 to 7.7). Slightly more children moved for S&J (44) compared with 38 for P&P.ConclusionsS&J produces more movement and longer paint marks than P&P. The risk of laceration when administering an EpiPen to young children may be lower by using the more controlled P&P. We feel it is advisable to teach P&P instead in children below 11 years of age.
Subject
Pediatrics, Perinatology and Child Health
Reference14 articles.
1. Second symposium on the definition and management of anaphylaxis: Summary report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium
2. Increase in anaphylaxis-related hospitalizations but no increase in fatalities: An analysis of United Kingdom national anaphylaxis data, 1992-2012
3. Pawanker R , Holgate ST , Canonica GW , et al , eds. White Book on Allergy: Update 2013. Milwaukee, Wisonsin, USA: World Allergy Organisation (WAO), 2013.
4. Medicines for Children . Adrenaline auto-injector for anaphylaxis [patient information leaflet. 2.2 ed. RCPCH, NPPG, WellChild, 2013: 1–2.
5. Medicines and Healthcare Products Regulatory Agency . Adrenaline Auto-Injectors: a review of clinical and quality considerations, 2014: 11.